Among 200 people with breast cancer at Mauritania's national oncology centre, the mean age was 50.46 years and about a third had waited three months or more before consulting. Of the 102 tumours tested, 35.3% were triple negative.
A letter to the editors reporting a retrospective study of 200 patients with usable clinical and pathology records, out of 429 breast cancers recorded at the Centre National d'Oncologie in 2020 and 2021, which were 15.71% of all cancers diagnosed there. The article is in French.
The authors point to two weaknesses: late diagnosis, and tumour testing that became reliably available at the centre in 2024 and is limited to hormone receptors, HER2 and Ki-67, with FISH not done locally.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/